You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 287 No. 7, February 20, 2002 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (59)
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in JAMA
 Topic Collections
 •Bacterial Infections
 •Bioterrorism
 •Diagnosis
 •Alert me on articles by topic

Fatal Inhalational Anthrax in a 94-Year-Old Connecticut Woman

Lydia A. Barakat, MD; Howard L. Quentzel, MD; John A. Jernigan, MD; David L. Kirschke, MD; Kevin Griffith, MD,MPH; Stephen M. Spear, MD; Katherine Kelley, PhD; Diane Barden, MT; Donald Mayo, ScD; David S. Stephens, MD; Tanja Popovic, MD,PhD; Chung Marston; Sherif R. Zaki, MD,PhD; Jeanette Guarner, MD; Wun-Ju Shieh, MD,PhD; H. Wayne Carver II, MD; Richard F. Meyer, PhD; David L. Swerdlow, MD; Eric E. Mast, MD,MPH; James L. Hadler, MD; for the Anthrax Bioterrorism Investigation Team

JAMA. 2002;287:863-868.

We describe the 11th case of bioterrorism-related inhalational anthrax reported in the United States. The presenting clinical features of this 94-year-old woman were subtle and nondistinctive. The diagnosis was recognized because blood cultures were obtained prior to administration of antibiotics, emphasizing the importance of this diagnostic test in evaluating ill patients who have been exposed to Bacillus anthracis. The patient's clinical course was characterized by progression of respiratory insufficiency, pleural effusions and pulmonary edema, and, ultimately, death. Although her B anthracis bacteremia was rapidly sterilized after initiation of antibiotic therapy, viable B anthracis was present in postmortem mediastinal lymph node specimens. The source of exposure to B anthracis in this patient is not known. Exposure to mail that was cross-contaminated as it passed through postal facilities contaminated with B anthracis spores is one hypothesis under investigation.


Author Affiliations: Griffin Hospital, Derby, Conn (Drs Barakat, Quentzel, and Spear); Centers for Disease Control and Prevention (Drs Jernigan, Kirschke, Griffith, Popovic, Zaki, Guarner, Shieh, Meyer, Swerdlow, and Mast and Ms Marston) and Emory University School of Medicine (Dr Stephens), Atlanta, Ga; Connecticut Department of Health (Drs Kelley, Mayo, and Hadler and Ms Barden) and the Connecticut State Medical Examiner's Office (Dr Carver), Hartford.


RELATED ARTICLES

Fatal Inhalational Anthrax With Unknown Source of Exposure in a 61-Year-Old Woman in New York City
Bushra Mina, J. P. Dym, Frank Kuepper, Raymond Tso, Carmina Arrastia, Irina Kaplounova, Hasan Faraj, Agnieszka Kwapniewski, Christopher M. Krol, Mayer Grosser, Jeffrey Glick, Steven Fochios, Athena Remolina, Ljiljana Vasovic, Jeffrey Moses, Thomas Robin, Maria DeVita, and Michael L. Tapper
JAMA. 2002;287(7):858-862.
ABSTRACT | FULL TEXT  

Cutaneous Anthrax Associated With Microangiopathic Hemolytic Anemia and Coagulopathy in a 7-Month-Old Infant
Abigail Freedman, Olubunmi Afonja, Mary Wu Chang, Farzad Mostashari, Martin Blaser, Guillermo Perez-Perez, Herb Lazarus, Robert Schacht, Jane Guttenberg, Michael Traister, and William Borkowsky
JAMA. 2002;287(7):869-874.
ABSTRACT | FULL TEXT  

Bioterrorism Preparedness and Response: Clinicians and Public Health Agencies as Essential Partners
Julie Louise Gerberding, James M. Hughes, and Jeffrey P. Koplan
JAMA. 2002;287(7):898-900.
EXTRACT | FULL TEXT  

February 20, 2002
JAMA. 2002;287(7):921-922.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Criteria for Validation of Methods in Microbial Forensics
Budowle et al.
Appl. Environ. Microbiol. 2008;74:5599-5607.
FULL TEXT  

Anthrax Vaccine and Public Health Policy
Weiss et al.
Am. J. Public Health 2007;97:1945-1951.
ABSTRACT | FULL TEXT  

Responding to a Small-scale Bioterrorist Anthrax Attack: Cost-effectiveness Analysis Comparing Preattack Vaccination With Postattack Antibiotic Treatment and Vaccination
Schmitt et al.
Arch Intern Med 2007;167:655-662.
ABSTRACT | FULL TEXT  

Discriminating Inhalational Anthrax From Community-Acquired Pneumonia Using Chest Radiograph Findings and a Clinical Algorithm
Kyriacou et al.
Chest 2007;131:489-496.
ABSTRACT | FULL TEXT  

Sepsis and Pathophysiology of Anthrax in a Nonhuman Primate Model
Stearns-Kurosawa et al.
Am. J. Pathol. 2006;169:433-444.
ABSTRACT | FULL TEXT  

Detection of Anthrax Toxin in the Serum of Animals Infected with Bacillus anthracis by Using Engineered Immunoassays
Mabry et al.
CVI 2006;13:671-677.
ABSTRACT | FULL TEXT  

Systematic review: a century of inhalational anthrax cases from 1900 to 2005.
Holty et al.
ANN INTERN MED 2006;144:270-280.
ABSTRACT | FULL TEXT  

Bacillus anthracis Edema Toxin Causes Extensive Tissue Lesions and Rapid Lethality in Mice
Firoved et al.
Am. J. Pathol. 2005;167:1309-1320.
ABSTRACT | FULL TEXT  

Pathophysiological Manifestations in Mice Exposed to Anthrax Lethal Toxin
Culley et al.
Infect. Immun. 2005;73:7006-7010.
ABSTRACT | FULL TEXT  

Rabbit and Nonhuman Primate Models of Toxin-Targeting Human Anthrax Vaccines
Phipps et al.
Microbiol. Mol. Biol. Rev. 2004;68:617-629.
ABSTRACT | FULL TEXT  

Rapid Assessment of Agents of Biological Terrorism: Defining the Differential Diagnosis of Inhalational Anthrax Using Electronic Communication in a Practice-Based Research Network
Temte and Anderson
Ann Fam Med 2004;2:434-437.
ABSTRACT | FULL TEXT  

The Primary Care Differential Diagnosis of Inhalational Anthrax
Temte and Zinkel
Ann Fam Med 2004;2:438-444.
ABSTRACT | FULL TEXT  

Differentiating Inhalational Anthrax From Other Influenzalike Illnesses in the Setting of a National or Regional Anthrax Outbreak
Cinti et al.
Arch Intern Med 2004;164:674-676.
ABSTRACT | FULL TEXT  

One hundred years of anthrax
Nicoll and Maynard
Occup. Environ. Med. 2004;61:95-95.
FULL TEXT  

The Critical Role of Pathology in the Investigation of Bioterrorism-Related Cutaneous Anthrax
Shieh et al.
Am. J. Pathol. 2003;163:1901-1910.
ABSTRACT | FULL TEXT  

Inhalational Anthrax: Radiologic and Pathologic Findings in Two Cases
Wood et al.
Am. J. Roentgenol. 2003;181:1071-1078.
FULL TEXT  

Accuracy of Screening for Inhalational Anthrax after a Bioterrorist Attack
Hupert et al.
ANN INTERN MED 2003;139:337-345.
ABSTRACT | FULL TEXT  

Pathology and Pathogenesis of Bioterrorism-Related Inhalational Anthrax
Guarner et al.
Am. J. Pathol. 2003;163:701-709.
ABSTRACT | FULL TEXT  

Characterization of Anthrolysin O, the Bacillus anthracis Cholesterol-Dependent Cytolysin
Shannon et al.
Infect. Immun. 2003;71:3183-3189.
ABSTRACT | FULL TEXT  

Secondary Aerosolization of Viable Bacillus anthracis Spores in a Contaminated US Senate Office
Weis et al.
JAMA 2002;288:2853-2858.
ABSTRACT | FULL TEXT  

Guest Editorial: Terrorism and Aging
Salerno and Nagy
J. Gerontol. A Biol. Sci. Med. Sci. 2002;57:M552-554.
FULL TEXT  

Anthrax as a Biological Weapon, 2002: Updated Recommendations for Management
Inglesby et al.
JAMA 2002;287:2236-2252.
ABSTRACT | FULL TEXT  

Bioterrorism Preparedness and Response: Clinicians and Public Health Agencies as Essential Partners
Gerberding et al.
JAMA 2002;287:898-900.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2002 American Medical Association. All Rights Reserved.